Munafa Stock Market Course + Intraday & FNO calls 
Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for USA stock GSK Glaxosmithkline Plc. Dated: 09 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 52.55 and Closed at: 52.48, which is -0.08% of previous session's close. It moved within a range of 52.30 and 52.85
The session was a Bearish session with an average volume of 2100485, which is -5.88% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 9 days back on mid term averages
Support for tomorrow is 52.12 and resistance for tomorrow is 52.67
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 52.24, 51.99 resistance for tomorrow's hourly charts is 52.79, 53.09
10 Day SMA for Glaxosmithkline Plc (GSK) is 52.6 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 52.21 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 51.35 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 53.86 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 50.9 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 52.21 and 200 DMA is at 50.9, while 50 DMA and 100 DMA are at 51.35 and 53.86 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 52.21 and 20 EMA is at 52.21
| Date | Closing Price | 20 SMA | 20 EMA |
| 09 Thu Jul | 52.48 | 52.21 | 52.21 |
| 08 Wed Jul | 52.52 | 52.15 | 52.18 |
| 07 Tue Jul | 53.32 | 52.06 | 52.14 |
| 06 Mon Jul | 53.09 | 51.97 | 52.02 |
| 02 Thu Jul | 53.66 | 51.88 | 51.91 |
| 01 Wed Jul | 51.30 | 51.68 | 51.73 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 51.35 and 50 EMA is at 52.24
| Date | Closing Price | 50 SMA | 50 EMA |
| 09 Thu Jul | 52.48 | 51.35 | 52.24 |
| 08 Wed Jul | 52.52 | 51.39 | 52.23 |
| 07 Tue Jul | 53.32 | 51.43 | 52.22 |
| 06 Mon Jul | 53.09 | 51.45 | 52.17 |
| 02 Thu Jul | 53.66 | 51.5 | 52.13 |
| 01 Wed Jul | 51.30 | 51.54 | 52.07 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 53.86 and 100 EMA is at 52.23
| Date | Closing Price | 100 SMA | 100 EMA |
| 09 Thu Jul | 52.48 | 53.86 | 52.23 |
| 08 Wed Jul | 52.52 | 53.93 | 52.23 |
| 07 Tue Jul | 53.32 | 53.99 | 52.22 |
| 06 Mon Jul | 53.09 | 54.04 | 52.2 |
| 02 Thu Jul | 53.66 | 54.1 | 52.18 |
| 01 Wed Jul | 51.30 | 54.15 | 52.15 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 50.9 and 200 EMA is at 50.13
| Date | Closing Price | 200 SMA | 200 EMA |
| 09 Thu Jul | 52.48 | 50.9 | 50.13 |
| 08 Wed Jul | 52.52 | 50.84 | 50.11 |
| 07 Tue Jul | 53.32 | 50.78 | 50.09 |
| 06 Mon Jul | 53.09 | 50.72 | 50.06 |
| 02 Thu Jul | 53.66 | 50.65 | 50.03 |
| 01 Wed Jul | 51.30 | 50.59 | 49.99 |
Glaxosmithkline Plc has performed better than Smith Nephew in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Eli Lilly has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Eli Lilly, about 4.51% more returns!
Davita Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Davita Inc, about 13.03% more returns!
Cvs Health has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Cvs Health, about 2.28% more returns!
Sarepta Therapeutics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Sarepta Therapeutics, about 33.24% more returns!
Rhythm Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 32.17% more returns!
Protagonist Therapeutics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Protagonist Therapeutics, about 27.66% more returns!
Prothena Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Prothena Corporation, about 19.31% more returns!
Glaxosmithkline Plc has performed better than Phio Pharmaceuticals in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Ovid Therapeutics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 11.48% more returns!
Oncolytics Biotech has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Oncolytics Biotech, about 14.94% more returns!
Lexicon Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Lexicon Pharmaceuticals, about 17.12% more returns!
Kura Oncology has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Kura Oncology, about 36.61% more returns!
Ironwood Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Ironwood Pharmaceuticals, about 36.84% more returns!
Fate Therapeutics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Fate Therapeutics, about 64.28% more returns!
Establishment Labs has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Establishment Labs, about 9.17% more returns!
Cumberland Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Cumberland Pharmaceuticals, about 7.66% more returns!
Compugen has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Compugen, about 23.97% more returns!
Glaxosmithkline Plc has performed better than Aptevo Therapeutics in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Glaxosmithkline Plc in short term and the buy signal is strong.
Glaxosmithkline Plc Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Glaxosmithkline Plc in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Glaxosmithkline Plc is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 52.63 and Glaxosmithkline Plc GSK stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
